ArticleCureus2026
Atraumatic Splenic Rupture: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atraumatic splenic rupture (ASR) is a rare but potentially fatal emergency, accounting for less than 0.5% of all splenic ruptures. Its nonspecific presentation often complicates diagnosis and management. True idiopathic ASR, occurring without an underlying splenic disease, is extremely rare. We report the case of a 61-year-old woman with diffuse large B-cell lymphoma in complete metabolic remission who developed sudden, severe epigastric and left upper quadrant pain 7 days after receiving high-dose methotrexate for central nervous system prophylaxis. There was no evidence of splenic involvement by lymphoma or other predisposing factors. The patient rapidly progressed to hemorrhagic shock. Imaging identified a large subcapsular splenic hematoma with active bleeding, necessitating emergent splenectomy. Following surgery, she achieved hemodynamic stabilization and recovered without postoperative complications, remaining disease-free at the six-month follow-up. Histopathological examination confirmed preserved splenic architecture without malignancy, vascular pathology, or amyloid deposition. This case highlights the risk of diagnostic anchoring bias in patients with a history of hematologic malignancy, as ASR may be incorrectly attributed to disease recurrence. In the absence of splenic involvement or identifiable risk factors, histopathological confirmation was essential to establish the diagnosis of true idiopathic ASR and to guide appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.